MKI67 and neoplasm: Moreover, the results of IHC indicated that Ki67 expression increased in the LUCAT1-overexpressing tumor tissues compared to the control group following osimertinib treatment, while no significant difference was observed between the two groups without the drug (Fig. 3H, I).